Model
Edge
Regeneron Pharmaceuticals, Inc.
0001681643
Filing type
4
Filing date
Jan 3, 2024
Updated
Jan 4, 2024 ยท 9:11 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership